ArticleBMC infectious diseases2022

Large-scale (Phase III) evaluation of broflanilide 50WP (VECTRON™ T500) for indoor residual spraying for malaria vector control in Northeast Tanzania: study protocol for a two-arm, non-inferiority, cluster-randomised community trial.

Patrick K Tungu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.